These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3578051)

  • 1. Hazards of intravenous verapamil for sustained ventricular tachycardia.
    Buxton AE; Marchlinski FE; Doherty JU; Flores B; Josephson ME
    Am J Cardiol; 1987 May; 59(12):1107-10. PubMed ID: 3578051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misuse of intravenous verapamil in patients with ventricular tachycardia.
    Rankin AC; Rae AP; Cobbe SM
    Lancet; 1987 Aug; 2(8557):472-4. PubMed ID: 2887775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and mechanisms of prevention and termination of verapamil-sensitive sustained ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hosoda S
    Am J Cardiol; 1989 Dec; 64(20):46J-49J. PubMed ID: 2480708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil in ventricular tachycardia.
    Hasin Y; Kriwisky M; Gotsman MS
    Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained ventricular tachycardia responsive to verapamil in patients with hypertrophic cardiomyopathy. Clinical and electrophysiological assessment of drug efficacy.
    Miyajima S; Aizawa Y; Suzuki K; Satoh M; Niwano S; Ebe K; Fujita T; Ishiguro J; Hirokawa Y; Shibata A
    Jpn Heart J; 1989 Mar; 30(2):241-9. PubMed ID: 2724542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent sustained ventricular tachycardia solely responsive to verapamil in a patient with a remote myocardial infarction.
    Belhassen B; Barasch E; Turgeman Y; Rosenfeld T; Laniado S
    Cardiology; 1988; 75(4):294-300. PubMed ID: 3167921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil responsive ventricular tachycardia: clinical and electrophysiologic characteristics.
    Sethi KK; Singh B; Kalra GS; Mohan JC; Jolly N; Arora R; Khalilullah M
    Indian Heart J; 1991; 43(6):437-43. PubMed ID: 1823891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of electrophysiologic and electropharmacologic characteristics of verapamil-sensitive ventricular tachycardia in patients without structural heart disease.
    Lee KL; Lauer MR; Young C; Lai WT; Tai YT; Chun H; Liem LB; Sung RJ
    Am J Cardiol; 1996 May; 77(11):967-73. PubMed ID: 8644647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with verapamil.
    Vohra J; Hunt D; Sloman G
    Med J Aust; 1975 Sep; 2(11):417-21. PubMed ID: 1186549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol.
    Buxton AE; Waxman HL; Marchlinski FE; Josephson ME
    Am J Cardiol; 1984 Mar; 53(6):738-44. PubMed ID: 6702622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of intravenous calcium before verapamil to prevent hypotension in elderly patients with paroxysmal supraventricular tachycardia.
    Miyagawa K; Dohi Y; Ogihara M; Sato K
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):273-9. PubMed ID: 7692169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.
    Sung RJ; Shapiro WA; Shen EN; Morady F; Davis J
    J Clin Invest; 1983 Jul; 72(1):350-60. PubMed ID: 6874951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease.
    German LD; Packer DL; Bardy GH; Gallagher JJ
    Am J Cardiol; 1983 Dec; 52(10):1202-7. PubMed ID: 6650408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic paroxysmal ventricular tachycardia with a QRS pattern of right bundle branch block and left axis deviation: a unique clinical entity with specific properties.
    Lin FC; Finley CD; Rahimtoola SH; Wu D
    Am J Cardiol; 1983 Jul; 52(1):95-100. PubMed ID: 6858937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroversion after verapamil administration.
    Soler-Soler J; Permanyer-Miralda G; Sagristá-Sauleda J; Noguera L; Larrousse E; Tornos MP
    Chest; 1983 Feb; 83(2):225-7. PubMed ID: 6822106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral-verapamil-induced sustained hypotension.
    Tucker RA; Serote WF
    Drug Intell Clin Pharm; 1984 Mar; 18(3):239-41. PubMed ID: 6697887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia.
    Epstein ML; Kiel EA; Victorica BE
    Pediatrics; 1985 Apr; 75(4):737-40. PubMed ID: 3982906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil preceded by calcium in supraventricular tachycardia.
    Stringer KA; Hicks P; Royal SH; Branconi JM; Sloan R
    Drug Intell Clin Pharm; 1988; 22(7-8):575-6. PubMed ID: 3416743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
    Griffith MJ; Linker NJ; Garratt CJ; Ward DE; Camm AJ
    Lancet; 1990 Sep; 336(8716):670-3. PubMed ID: 1975861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained ventricular tachycardia in the emergency department.
    Domanovits H; Paulis M; Nikfardjam M; Holzer M; Stühlinger HG; Hirschl MM; Laggner AN
    Resuscitation; 1999 Sep; 42(1):19-25. PubMed ID: 10524728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.